These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 31577283)
41. Targeting Energy Metabolism by a Platinum(IV) Prodrug as an Alternative Pathway for Cancer Suppression. Jin S; Guo Y; Song D; Zhu Z; Zhang Z; Sun Y; Yang T; Guo Z; Wang X Inorg Chem; 2019 May; 58(9):6507-6516. PubMed ID: 31013065 [TBL] [Abstract][Full Text] [Related]
42. Dinuclear berenil-platinum (II) complexes as modulators of apoptosis in human MCF-7 and MDA-MB231 breast cancer cells. Agnieszka G; Ewa A; Anna B; Krzysztof B; Monika C; Elżbieta S Anticancer Agents Med Chem; 2014; 14(8):1179-86. PubMed ID: 24954860 [TBL] [Abstract][Full Text] [Related]
43. Pt(II) squares as selective and effective human telomeric G-quadruplex binders and potential cancer therapeutics. Zheng XH; Zhong YF; Tan CP; Ji LN; Mao ZW Dalton Trans; 2012 Oct; 41(38):11807-12. PubMed ID: 22907716 [TBL] [Abstract][Full Text] [Related]
44. Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells. Lu JJ; Fu L; Tang Z; Zhang C; Qin L; Wang J; Yu Z; Shi D; Xiao X; Xie F; Huang W; Deng W Oncotarget; 2016 Jan; 7(3):2985-3001. PubMed ID: 26672764 [TBL] [Abstract][Full Text] [Related]
45. A novel series of pyrazole-platinum(II) complexes as potential anti-cancer agents that induce cell cycle arrest and apoptosis in breast cancer cells. Czarnomysy R; Surażyński A; Muszynska A; Gornowicz A; Bielawska A; Bielawski K J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1006-1023. PubMed ID: 29862867 [TBL] [Abstract][Full Text] [Related]
46. Jatrorrhizine inhibits mammary carcinoma cells by targeting TNIK mediated Wnt/β-catenin signalling and epithelial-mesenchymal transition (EMT). Sun Y; Gao X; Wu P; Wink M; Li J; Dian L; Liang Z Phytomedicine; 2019 Oct; 63():153015. PubMed ID: 31302315 [TBL] [Abstract][Full Text] [Related]
48. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells. Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588 [TBL] [Abstract][Full Text] [Related]
49. Cytotoxicity profile of novel sterically hindered platinum(II) complexes with (1R,2R)-N(1),N(2)-dibutyl-1,2-diaminocyclohexane. Zhang H; Gou S; Zhao J; Chen F; Xu G; Liu X Eur J Med Chem; 2015; 96():187-95. PubMed ID: 25874342 [TBL] [Abstract][Full Text] [Related]
50. Homo- and heteroleptic Pt(II) complexes of ONN donor hydrazone and 4-picoline: A synthetic, structural and detailed mechanistic anticancer investigation. Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Yang B; Koppireddi S; Lin Y; Wang H; Li ZT; Zhang DW Eur J Med Chem; 2018 Jan; 143():1039-1052. PubMed ID: 29232581 [TBL] [Abstract][Full Text] [Related]
51. A Novel Platinum-based Compound with Preferential Cytotoxic Activity against a Panel of Cancer Cell Lines. Shahsavar F; Bozorgmehr M; Mirzadegan E; Abedi A; Lighvan ZM; Mohammadi F; Safari N; Amani V; Zarnani AH Anticancer Agents Med Chem; 2016; 16(3):393-403. PubMed ID: 26899296 [TBL] [Abstract][Full Text] [Related]
52. Pt-rotaxanes as cytotoxic agents. Wang X; Smithrud DB Bioorg Med Chem Lett; 2011 Nov; 21(22):6880-3. PubMed ID: 21978681 [TBL] [Abstract][Full Text] [Related]
53. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity. Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355 [TBL] [Abstract][Full Text] [Related]
54. Synthesis and evaluation of series of diazine-bridged dinuclear platinum(II) complexes through in vitro toxicity and molecular modeling: correlation between structure and activity of Pt(II) complexes. Senerovic L; Zivkovic MD; Veselinovic A; Pavic A; Djuran MI; Rajkovic S; Nikodinovic-Runic J J Med Chem; 2015 Feb; 58(3):1442-51. PubMed ID: 25551180 [TBL] [Abstract][Full Text] [Related]
55. ONS-donor ligand based Pt(II) complexes display extremely high anticancer potency through autophagic cell death pathway. Rahman FU; Ali A; Duong HQ; Khan IU; Bhatti MZ; Li ZT; Wang H; Zhang DW Eur J Med Chem; 2019 Feb; 164():546-561. PubMed ID: 30622026 [TBL] [Abstract][Full Text] [Related]
56. Antiproliferative effect of novel platinum(II) and palladium(II) complexes on hepatic tumor stem cells in vitro. Miklášová N; Fischer-Fodor E; Lönnecke P; Tomuleasa CI; Virag P; Schrepler MP; Mikláš R; Dumitrescu LS; Hey-Hawkins E Eur J Med Chem; 2012 Mar; 49():41-7. PubMed ID: 22305340 [TBL] [Abstract][Full Text] [Related]
57. A Pt(IV) Prodrug Combining Chlorambucil and Cisplatin: a Dual-Acting Weapon for Targeting DNA in Cancer Cells. Montagner D; Tolan D; Andriollo E; Gandin V; Marzano C Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486477 [TBL] [Abstract][Full Text] [Related]
58. Uptake of antitumor platinum(II)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS). Ghezzi A; Aceto M; Cassino C; Gabano E; Osella D J Inorg Biochem; 2004 Jan; 98(1):73-8. PubMed ID: 14659635 [TBL] [Abstract][Full Text] [Related]
59. New Platinum(II) agent induces bimodal death of apoptosis and autophagy against A549 cancer cell. Wang FY; Huang KB; Feng HW; Chen ZF; Liu YN; Liang H Free Radic Biol Med; 2018 Dec; 129():418-429. PubMed ID: 30266678 [TBL] [Abstract][Full Text] [Related]
60. Acetonimine and 4-imino-2-methylpentan-2-amino platinum(II) complexes: synthesis and in vitro antitumor activity. Ruiz J; Rodríguez V; Cutillas N; López G; Bautista D Inorg Chem; 2008 Nov; 47(21):10025-36. PubMed ID: 18844342 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]